Delisting risk
XAIR · NASDAQ · Medical - Devices

Beyond Air (XAIR)

Makes an ambient-air nitric oxide system for newborn respiratory care.

$3.61
Pre-market−0.01 (−0.22%)
At close$3.62(−1.09%)

In millions of USD, except per-share figures

In millionsQ2 FY24Sep 2023Q3 FY24Dec 2023Q4 FY24Mar 2024Q1 FY25Jun 2024Q2 FY25Sep 2024Q3 FY25Dec 2024Q4 FY25Mar 2025Q1 FY26Jun 2025Q2 FY26Sep 2025Q3 FY26Dec 2025Q4 FY26Mar 2026Q1 FY27Jun 2026
Revenue000111122222
Cost of revenue011121122222
Gross profit00−10−10000000
171712131211787777
Research & development776653332222
10106778455455
Selling & marketing050000000000
General & administrative1056778455455
Other expenses000000000000
Operating income−18−17−13−14−13−11−7−8−8−7−7−7
00−21−1−2−10−1−1−3−2
Interest income000000000000
Interest expense1111111111−21
Other non-operating income−1−11−102000050
Income before tax−17−17−15−13−14−13−8−8−8−8−10−8
Net income from continuing operations−17−17−15−13−14−13−8−8−8−8−10−8
Other adjustments000000000000
Net income−16−16−14−12−13−13−8−8−8−7−10−8
EPS, basic−$204.00−$199.80−$142.80−$106.40−$113.40−$59.20−$35.80−$30.60−$25.00−$17.00−$0.60−$11.00
EPS, diluted−$204.00−$199.80−$142.80−$106.40−$113.40−$59.20−$35.80−$30.60−$25.00−$17.00−$0.60−$11.00
Weighted average shares, basic081
Weighted average shares, diluted081
EBITDA−16−16−13−11−12−12−7−7−7−6−12−6
Depreciation & amortization111111111100
EBIT−17−16−14−12−13−13−7−8−8−7−13−6